ATE271872T1 - Topische carbamazepin-formulierungen und deren verwendung - Google Patents

Topische carbamazepin-formulierungen und deren verwendung

Info

Publication number
ATE271872T1
ATE271872T1 AT98967074T AT98967074T ATE271872T1 AT E271872 T1 ATE271872 T1 AT E271872T1 AT 98967074 T AT98967074 T AT 98967074T AT 98967074 T AT98967074 T AT 98967074T AT E271872 T1 ATE271872 T1 AT E271872T1
Authority
AT
Austria
Prior art keywords
carbamazepine
patient
skin
topically
vehicle
Prior art date
Application number
AT98967074T
Other languages
English (en)
Inventor
Marc Coles
Original Assignee
Taro Pharmaceuticals Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taro Pharmaceuticals Usa Inc filed Critical Taro Pharmaceuticals Usa Inc
Application granted granted Critical
Publication of ATE271872T1 publication Critical patent/ATE271872T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98967074T 1997-12-19 1998-12-18 Topische carbamazepin-formulierungen und deren verwendung ATE271872T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6837097P 1997-12-19 1997-12-19
PCT/US1998/026919 WO1999031987A1 (en) 1997-12-19 1998-12-18 Topical carbamazepine formulations and methods of use

Publications (1)

Publication Number Publication Date
ATE271872T1 true ATE271872T1 (de) 2004-08-15

Family

ID=22082120

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98967074T ATE271872T1 (de) 1997-12-19 1998-12-18 Topische carbamazepin-formulierungen und deren verwendung

Country Status (10)

Country Link
US (2) US6486152B1 (de)
EP (1) EP1061802B1 (de)
JP (1) JP2001526194A (de)
AT (1) ATE271872T1 (de)
AU (1) AU749301B2 (de)
CA (1) CA2314868A1 (de)
DE (1) DE69825322T2 (de)
ES (1) ES2226205T3 (de)
IL (1) IL136807A0 (de)
WO (1) WO1999031987A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL136807A0 (en) * 1997-12-19 2001-06-14 Taro Pharmaceuticals Usa Inc Topical carbamazepine formulation and methods of use
US20060003966A1 (en) * 2004-06-16 2006-01-05 Jack Arbiser Carbazole formulations for the treatment of psoriasis and angiogenesis
CN113116826A (zh) * 2021-04-20 2021-07-16 河北医科大学 一种局部外用的卡马西平纳米制剂及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4034087A (en) * 1973-12-17 1977-07-05 The Regents Of The University Of Michigan Pharmaceutical composition and process of treatment
US4690775A (en) * 1983-09-30 1987-09-01 Research Corporation Emulsion-based gel and process for preparing same
US4758554A (en) * 1984-08-14 1988-07-19 International Copper Research Association Method for treating convulsions and epilepsy with organic copper compounds
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
US5107356A (en) 1989-12-26 1992-04-21 General Electric Company Liquid crystal display device with birefringent films
EP0435826A1 (de) * 1989-12-27 1991-07-03 Ciba-Geigy Ag Intravenöse Lösungen für Status Epilepticus
CH681152A5 (de) * 1991-06-04 1993-01-29 Marigen S.A. Neue biotenside und antitumorale ester und phosphatide mit vitamin-d- und vitamin-e-verbindungen, ihre herstellung und aufarbeitung zu spontan dispergierbaren konzentraten.
CA2075517C (en) 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
US5472954A (en) 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
US5234929A (en) 1992-07-20 1993-08-10 William Chelen Method of treating motion sickness with anticonvulsants and antitussive agents
US5952004A (en) * 1994-03-18 1999-09-14 Shire Laboratories Inc. Emulsified drug delivery systems
US5466683A (en) * 1994-08-25 1995-11-14 Teva Pharmaceutical Industries Ltd. Water-soluble analogs of carbamazepine
US5466712A (en) 1994-11-04 1995-11-14 American Home Products Corporation Substituted n-aryl-1,2-diaminocyclobutene-3,4-diones
DE4440337A1 (de) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
US6290986B1 (en) * 1996-10-24 2001-09-18 Pharmaceutical Applications Associates, Llc Method and composition for transdermal administration of pharmacologic agents
US6572880B2 (en) * 1996-10-24 2003-06-03 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
IL136807A0 (en) * 1997-12-19 2001-06-14 Taro Pharmaceuticals Usa Inc Topical carbamazepine formulation and methods of use
US5900249A (en) * 1998-02-09 1999-05-04 Smith; David J. Multicomponent pain relief topical medication

Also Published As

Publication number Publication date
US20020198192A1 (en) 2002-12-26
JP2001526194A (ja) 2001-12-18
DE69825322D1 (de) 2004-09-02
ES2226205T3 (es) 2005-03-16
AU749301B2 (en) 2002-06-20
EP1061802B1 (de) 2004-07-28
EP1061802A1 (de) 2000-12-27
IL136807A0 (en) 2001-06-14
AU1831299A (en) 1999-07-12
CA2314868A1 (en) 1999-07-01
US6486152B1 (en) 2002-11-26
DE69825322T2 (de) 2005-07-14
WO1999031987A1 (en) 1999-07-01
EP1061802A4 (de) 2002-01-23

Similar Documents

Publication Publication Date Title
WO2000027381A3 (en) Topical application of muscarinic agents such as neostigmine for treatment of acne and other inflammatory conditions
EP2158907A3 (de) topische Arginin-Verabreichung zur Schmerzbehandlung
PT2450043T (pt) Composição farmacêutica para uso dérmico no tratamento de psoríase compreendendo calcipotriol e betametasona
GR3027749T3 (en) Cosmetic or pharmaceutical composition for topical application active against free radicals.
AU674142B2 (en) Use of cosmetic composition
DE68912195D1 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
MX9603596A (es) Perfluoropolieteres o composiciones de los mismos para prevencion y tratamiento de infecciones virales topicas.
DE3685696D1 (de) Melatoninhaltige mittel sowie deren verwendungen.
PH31607A (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatosis.
ES2111102T3 (es) Formulaciones cosmeticas y dermatologicas con un contenido activo en acido cis-urocaninico.
BG101126A (en) The use of muramylpeptide compounds
DK0700897T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme til behandling af hudsygdomme
ATE271872T1 (de) Topische carbamazepin-formulierungen und deren verwendung
EP0279867A3 (de) Verwendung von Vitamin-E und Vitamin-E-Kombination mit nichtsteroidalen Antirheumatika und Schmerzmittel zur Behandlung von rheumatischen Erkrankungen
PT1063978E (pt) Metodo de tratamento de dor de neuroma
KR960706345A (ko) 건선 치료(Psoriasis treatment)
PT1140001E (pt) Composicao para tratamento de queimaduras
Berg Emollient creams in the treatment of psoriasis: a study of patient preference
MC2450A1 (fr) Composition pour le traitement topique d'affections de la peau et des phanères
UA30421A (uk) Компрес для лікування запального процесу і болю
IT1264335B (it) Uso topico di composizioni farmaceutiche a base di piricarbato nel trattamento delle alopecie primitive o secondarie e della psoriasi
IL105296A0 (en) Pharmaceutical formulation for topical application in the treatment of dry skin
IT1264428B1 (it) Composizioni farmaceutiche per il trattamento della psoriasi
TH50863A3 (th) องค์ประกอบที่ใช้รักษาผิวหนัง
CA2255521A1 (en) Compositions for treatment of burns

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties